Is Summit Therapeutics a Buy Now?
The Motley FoolThe clinical-stage drugmaker’s cancer therapy candidate outperformed Keytruda, the world’s top-selling cancer drug.
The clinical-stage drugmaker’s cancer therapy candidate outperformed Keytruda, the world’s top-selling cancer drug.